Background: Obesity is a metabolic disorder and an immunomodulatory factor that
may play an essential role in the pathogenesis of autoimmune diseases. Chronic
low-grade inflammation associated with excess body fat can lead to impaired
immune tolerance and activation of autoimmune responses. Aim: The aim of our
systematic review focused on assessing the impact of obesity on selected
autoimmune diseases. Materials and Methods: The databases Pubmed and Google
Scholar were searched for the years from 2000 to 2024. Researchers searched using
the keywords: “obesity and autoimmunity”, “adipokines and inflammation” ,
“obesity and type 1 diabetes” , “obesity and Hashimoto's thyroiditis”, “obesity and
rheumatoid arthritis”, and “obesity and psoriasis”. This review includes original
studies, reviews, and meta-analyses on the relationship between obesity and
autoimmunity. Results: The article describes the impact of obesity on the immune
system, taking into account the role of leptin and adiponectin, among others.
Furthermore, it highlights the correlation between obesity and autoimmune
diseases, particularly type 1 diabetes, Hashimoto’s disease, psoriasis, and
rheumatoid arthritis. Research shows that obesity can exacerbate disease symptoms,
worsen response to treatment, and increase the risk of complications. Conclusions:
Obesity has multiple effects on the course of autoimmune diseases. Weight
reduction may provide therapeutic benefits by reducing inflammation and
improving response to treatment.
Keywords: obesity, autoimmune diseases, adipokines, inflammation, immune
system